SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023671
Filing Date
2020-11-12
Accepted
2020-11-12 17:08:07
Documents
42
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20200930_10q.htm 10-Q 589878
2 EXHIBIT 4.1 ex_213674.htm EX-4.1 67347
3 EXHIBIT 31.1 ex_200522.htm EX-31.1 19609
4 EXHIBIT 31.2 ex_200523.htm EX-31.2 14573
5 EXHIBIT 32.1 ex_200524.htm EX-32.1 10503
  Complete submission text file 0001437749-20-023671.txt   3344216

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gnpx-20200930.xml EX-101.INS 479378
7 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20200930.xsd EX-101.SCH 37080
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20200930_cal.xml EX-101.CAL 20150
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20200930_def.xml EX-101.DEF 269951
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20200930_lab.xml EX-101.LAB 253433
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20200930_pre.xml EX-101.PRE 284994
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 201307899
SIC: 2834 Pharmaceutical Preparations